Back

The impact of age of onset and duration of Type 2 diabetes on life expectancy and serious health outcomes

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (3) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jetish Isufi

Sahlgrenska University Hospital, Gothenburg (Sweden)

4 More presentations in this session

Presentation thumbnail
Progressive disease substrate in obese type 2 diabetic patients with coronary artery disease despite achieving HbA1c <7.0%: sub-analysis from the OPTIMAL randomized study
Doctor A. Salib (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonists and SGLT2-inhibitors in patients with diabetes and ischaemic heart disease in primary care
Doctor T. Andersson (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Use of cardioprotective glucose lowering therapy before and after myocardial infarction among patients with type-2 diabetes: a nationwide registry study
Ms B. Sharad (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Tirzepatide and the risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials
Doctor E. Mansouri (Tehran, IR) Mr L. Barbosa (Belo Horizonte, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (3)

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources